In a report released yesterday, Deane Dray from RBC Capital maintained a Sell rating on 3M (MMM – Research Report), with a price target of ...

In a report released yesterday, Michael Dahl from RBC Capital maintained a Sell rating on DR Horton (DHI – Research Report), with a price ...

On Thursday, RBC Capital Markets adjusted its outlook on shares of JPMorgan Chase & Co. (NYSE: NYSE:JPM) shares by increasing the price target to $260 from the previous $248, while retaining an ...

In his latest memo named “On Bubble Watch,” Howard Marks, co-founder and co-chairman of Oaktree Capital, highlighted several ...

On Thursday, RBC Capital Markets adjusted its outlook on shares of JPMorgan Chase & Co. (NYSE: NYSE:JPM) shares by increasing the price target to $260 from the previous $248, while retaining an ...

J.P. Morgan analysts said the CMS’ review “validates the technology and could potentially move the needle on growth for Medtronic.” ...

Hedge funds have positioned for Donald Trump's U.S. presidency with their highest levels of borrowing since 2010, while ...

U.S. stock-trading hedge funds kicked off the week with gross leverage levels in their highest range since 2010.

According to the JP Morgan report, AI investing ... connects buyers with global suppliers for efficient production. RBC Capital increased its price target for Xometry, Inc. (NASDAQ:XMTR) from ...